Abstract
Data comparing the occurrence of gastroesophageal cancer after gastric bypass procedures are lacking and are only available in the form of case reports. We perform in this study a systematic review and a meta-analysis of all the reported cases of gastroesophageal cancer following Roux-en-Y gastric bypass (RYGB) and loop gastric bypass-one anastomosis gastric bypass/mini gastric bypass (LGB-OAGB/MGB). We conducted a systematic review of all the reported cases in articles referenced in PubMed/Medline, Cochrane, and Scholar Google. Only cases of gastro-esophageal adenocarcinoma following RYGB or LGB-OAGB/MGB are included. Statistical analysis was done accordingly. Fifty cases were identified, along with 2 reported in this paper. Sixty-one percent (27/44) of the cancers after RYGB were in the gastric tube compared to 37.5% (3/8) after LGB-OAGB/MGB. This resulted in an odds ratio of 0.38 (p-value = 0.26), which failed to prove an increase in cancer occurrence in the gastric tube after LGB-MGB/OAGB compared to RYGB. The most common symptoms were dysphagia for cancers occurring in the gastric tube (15/30) and abdominal pain for those occurring in the excluded stomach (10/22). Twenty-nine/thirty of the cancers in the gastric tube were diagnosed by gastroscopy and 13/22 of the cancers in the excluded stomach were diagnosed by CT scan. Gastroesophageal cancers after gastric bypass procedures occur commonly in the excluded stomach where many are not identified by conventional means. Physician awareness and patient education as well as lifelong follow-up are essential for maintaining bypass surgeries on the beneficial side.
Similar content being viewed by others
References
Organization WH. Overweight and Obesity [Internet]. 2017. Available from: https://www.who.int/gho/ncd/risk_factors/overweight_obesity/obesity_adults/en/.
Renehan AG, Tyson M, Egger M, Heller RF, Zwahlen M. Body-mass index and incidence of cancer: a systematic review and meta-analysis of prospective observational studies. Lancet. 2008;371(9612):569–78. https://doi.org/10.1016/S0140-6736(08)60269-X.
Adams TD, Hunt SC. Cancer and obesity: effect of bariatric surgery. World J Surg. 2009;33(10):2028–33. https://doi.org/10.1007/s00268-009-0169-1.
Upala S, Sanguankeo A. Bariatric surgery reduces risk of endometrial cancer. Surg Obes Relat Dis. 2015;11(6):1410. https://doi.org/10.1016/j.soard.2015.08.501.
Afshar S, Kelly SB, Seymour K, Lara J, Woodcock S, Mathers JC. The effects of bariatric surgery on colorectal cancer risk: systematic review and meta-analysis. Obes Surg. 2014;24(10):1793–9. https://doi.org/10.1007/s11695-014-1359-y.
Tee MC, Cao Y, Warnock GL, Hu FB, Chavarro JE. Effect of bariatric surgery on oncologic outcomes: a systematic review and meta-analysis. Surg Endosc. 2013;27(12):4449–56. https://doi.org/10.1007/s00464-013-3127-9.
Casagrande DS, Rosa DD, Umpierre D, Sarmento RA, Rodrigues CG, Schaan BD. Incidence of cancer following bariatric surgery: systematic review and meta-analysis. Obes Surg. 2014;24(9):1499–509. https://doi.org/10.1007/s11695-014-1276-0.
Borbély Y, Schaffner E, Zimmermann L, Huguenin M, Plitzko G, Nett P, Kröll D. De novo gastroesophageal reflux disease after sleeve gastrectomy: role of preoperative silent reflux. Surg Endosc. 2019;33(3):789–93. https://doi.org/10.1007/s00464-018-6344-4.
Qumseya BJ, Qumsiyeh Y, Ponniah SA, Estores D, Yang D, Johnson-Mann CN, Friedman J, Ayzengart A, Draganov PV. Barrett’s esophagus after sleeve gastrectomy: a systematic review and meta-analysis. Gastrointest Endosc. 2021;93(2):343-352.e2. https://doi.org/10.1016/j.gie.2020.08.008.
Scozzari G, Trapani R, Toppino M, Morino M. Esophagogastric cancer after bariatric surgery: systematic review of the literature. Surg Obes Relat Dis. 2013;9(1):133–42. https://doi.org/10.1016/j.soard.2012.10.002.
Orlando G, Pilone V, Vitiello A, Gervasi R, Lerose MA, Silecchia G, Puzziello A. Gastric cancer following bariatric surgery: a review. Surg Laparosc Endosc Percutan Tech. 2014;24(5):400–5. https://doi.org/10.1097/SLE.0000000000000050.
Team RC. R: a language and environment for statistical computing [Internet]. R Foundation for Statistical Computing, Vienna, Austria. 2017. Available from: https://www.r-project.org/.
Buchwald H, Avidor Y, Braunwald E, Jensen MD, Pories W, Fahrbach K, Schoelles K. Bariatric surgery: a systematic review and meta-analysis. JAMA. 2004;292(14):1724–37. https://doi.org/10.1001/jama.292.14.1724.
Poirier P, Cornier MA, Mazzone T, Stiles S, Cummings S, Klein S, McCullough PA, Ren Fielding C, Franklin BA, American Heart Association Obesity Committee of the Council on Nutrition, Physical Activity, and Metabolism. Bariatric surgery and cardiovascular risk factors: a scientific statement from the American Heart Association. Circulation. 2011;123(15):1683–701. https://doi.org/10.1161/CIR.0b013e3182149099.
Rutledge R, Walsh TR. Continued excellent results with the mini-gastric bypass: six-year study in 2,410 patients. Obes Surg. 2005;15(9):1304–8. https://doi.org/10.1381/096089205774512663.
García-Caballero M, Carbajo M. One anastomosis gastric bypass: a simple, safe and efficient surgical procedure for treating morbid obesity. Nutr Hosp. 2004;19(6):372–5.
Takeno S, Hashimoto T, Maki K, Shibata R, Shiwaku H, Yamana I, Yamashita R, Yamashita Y. Gastric cancer arising from the remnant stomach after distal gastrectomy: a review. World J Gastroenterol. 2014;20(38):13734–40. https://doi.org/10.3748/wjg.v20.i38.13734.
Rutledge R. The mini-gastric bypass: experience with the first 1,274 cases. Obes Surg. 2001;11(3):276–80. https://doi.org/10.1381/096089201321336584.
Noun R, Skaff J, Riachi E, Daher R, Antoun NA, Nasr M. One thousand consecutive mini-gastric bypass: short- and long-term outcome. Obes Surg. 2012;22(5):697–703. https://doi.org/10.1007/s11695-012-0618-z.
Jammu GS, Sharma R. A 7-year clinical audit of 1107 cases comparing sleeve gastrectomy, Roux-En-Y gastric bypass, and mini-gastric bypass, to determine an effective and safe bariatric and metabolic procedure. Obes Surg. 2016;26(5):926–32. https://doi.org/10.1007/s11695-015-1869-2.
Tolone S, Cristiano S, Savarino E, Lucido FS, Fico DI, Docimo L. Effects of omega-loop bypass on esophagogastric junction function. Surg Obes Relat Dis. 2016;12(1):62–9. https://doi.org/10.1016/j.soard.2015.03.011.
Doulami G, Triantafyllou S, Albanopoulos K, Natoudi M, Zografos G, Theodorou D. Acid and nonacid gastroesophageal reflux after single anastomosis gastric bypass. An objective assessment using 24-hour multichannel intraluminal impedance-pH metry. Surg Obes Relat Dis. 2018;14(4):484–8. https://doi.org/10.1016/j.soard.2017.10.012.
Keleidari B, Mahmoudieh M, DavarpanahJazi AH, Melali H, Nasr Esfahani F, Minakari M, Mokhtari M. Comparison of the bile reflux frequency in one anastomosis gastric bypass and Roux-en-Y gastric bypass: a cohort study. Obes Surg. 2019;29(6):1721–5. https://doi.org/10.1007/s11695-018-03683-6.
Saarinen T, Räsänen J, Salo J, Loimaala A, Pitkonen M, Leivonen M, Juuti A. Bile reflux scintigraphy after mini-gastric bypass. Obes Surg. 2017;27(8):2083–9. https://doi.org/10.1007/s11695-017-2608-7.
Bruzzi M, Duboc H, Gronnier C, Rainteau D, Couvelard A, Le Gall M, Bado A, Chevallier JM. Long-term evaluation of biliary reflux after experimental one-anastomosis gastric bypass in rats. Obes Surg. 2017;27(4):1119–22. https://doi.org/10.1007/s11695-017-2577-x.
Siebert M, Ribeiro-Parenti L, Nguyen ND, Hourseau M, Duchêne B, Humbert L, Jonckheere N, Nuel G, Chevallier JM, Duboc H, Rainteau D, Msika S, Kapel N, Couvelard A, Bado A, Le Gall M. Long-term consequences of one anastomosis gastric bypass on esogastric mucosa in a preclinical rat model. Sci Rep. 2020;10(1):7393. https://doi.org/10.1038/s41598-020-64425-2.
Donohoe CL, O’Farrell NJ, Doyle SL, Reynolds JV. The role of obesity in gastrointestinal cancer: evidence and opinion. Therap Adv Gastroenterol. 2014;7(1):38–50. https://doi.org/10.1177/1756283X13501786.
Pallati PK, Shaligram A, Shostrom VK, Oleynikov D, McBride CL, Goede MR. Improvement in gastroesophageal reflux disease symptoms after various bariatric procedures: review of the Bariatric Outcomes Longitudinal Database. Surg Obes Relat Dis. 2014;10(3):502–7. https://doi.org/10.1016/j.soard.2013.07.018.
Varban OA, Hawasli AA, Carlin AM, Genaw JA, English W, Dimick JB, Wood MH, Birkmeyer JD, Birkmeyer NJ, Finks JF. Variation in utilization of acid-reducing medication at 1 year following bariatric surgery: results from the Michigan Bariatric Surgery Collaborative. Surg Obes Relat Dis. 2015;11(1):222–8. https://doi.org/10.1016/j.soard.2014.04.027.
Suter M. Gastroesophageal reflux disease, obesity, and Roux-en-Y gastric bypass: complex relationship-a narrative review. Obes Surg. 2020;30(8):3178–87. https://doi.org/10.1007/s11695-020-04690-2.
Sundbom M, Hedenström H, Gustavsson S. Duodenogastric bile reflux after gastric bypass: a cholescintigraphic study. Dig Dis Sci. 2002;47(8):1891–6. https://doi.org/10.1023/a:1016429603337.
Ravacci GR, Ishida R, Torrinhas RS, Sala P, Machado NM, Fonseca DC, André Baptista Canuto G, Pinto E, Nascimento V, Franco Maggi Tavares M, Sakai P, Faintuch J, Santo MA, Moura EGH, Neto RA, Logullo AF, Waitzberg DL. Potential premalignant status of gastric portion excluded after Roux en-Y gastric bypass in obese women: a pilot study. Sci Rep. 2019;9(1):5582. https://doi.org/10.1038/s41598-019-42082-4.
Ahmad BN, Ahmad WN, Aalam WK, Ahmad SM, Hussain KS. Duodenogastric reflux, an important cause of post cholecystectomy symptoms. JK Pract. 2003;10(3):188–90.
Kumar N, Thompson CC. Remnant gastropathy due to bile reflux after Roux-en-Y gastric bypass: a unique cause of abdominal pain and successful treatment with ursodiol. Surg Endosc. 2017;31(12):5399–402. https://doi.org/10.1007/s00464-017-5621-y.
Csendes A, Burdiles P, Papapietro K, Diaz JC, Maluenda F, Burgos A, Rojas J. Results of gastric bypass plus resection of the distal excluded gastric segment in patients with morbid obesity. J Gastrointest Surg. 2005;9(1):121–31. https://doi.org/10.1016/j.gassur.2004.05.006.
Vella E, Hovorka Z, Yarbrough DE, McQuitty E. Bile reflux of the remnant stomach following Roux-en-Y gastric bypass: an etiology of chronic abdominal pain treated with remnant gastrectomy. Surg Obes Relat Dis. 2017;13(8):1278–83. https://doi.org/10.1016/j.soard.2017.04.007.
Raijman I, Strother SV, Donegan WL. Gastric cancer after gastric bypass for obesity. Case report J Clin Gastroenterol. 1991;13(2):191–4. https://doi.org/10.1097/00004836-199104000-00015.
Lord RV, Edwards PD, Coleman MJ. Gastric cancer in the bypassed segment after operation for morbid obesity. Aust N Z J Surg. 1997;67(8):580–2. https://doi.org/10.1111/j.1445-2197.1997.tb02047.x.
Khitin L, Roses RE, Birkett DH. Cancer in the gastric remnant after gastric bypass: a case report. Curr Surg. 2003;60(5):521–3. https://doi.org/10.1016/S0149-7944(03)00052-7.
Babor R, Booth M. Adenocarcinoma of the gastric pouch 26 years after loop gastric bypass. Obes Surg. 2006;16(7):935–8. https://doi.org/10.1381/096089206777822223.
Swain JM, Adams RB, Farnell MB, Que FG, Sarr MG. Gastric and pancreatoduodenal resection for malignant lesions after previous gastric bypass–diagnosis and methods of reconstruction. Surg Obes Relat Dis. 2010;6(6):670–5. https://doi.org/10.1016/j.soard.2010.03.287.
Wu CC, Lee WJ, Ser KH, Chen JC, Tsou JJ, Chen SC, Kuan WS. Gastric cancer after mini-gastric bypass surgery: a case report and literature review. Asian J Endosc Surg. 2013;6(4):303–6. https://doi.org/10.1111/ases.12052.
Allen JW, Leeman MF, Richardson JD. Esophageal carcinoma following bariatric procedures. JSLS. 2004;8(4):372–5.
Escalona A, Guzmán S, Ibáñez L, Meneses L, Huete A, Solar A. Gastric cancer after Roux-en-Y gastric bypass. Obes Surg. 2005;15(3):423–7. https://doi.org/10.1381/0960892053576668.
Trincado MT, del Olmo JC, GarcíaCastaño J, Cuesta C, Blanco JI, Awad S, Carbajo MA. Gastric pouch carcinoma after gastric bypass for morbid obesity. Obes Surg. 2005;15(8):1215–7. https://doi.org/10.1381/0960892055002383.
Nguyen NT, Tran CL, Gelfand DV, Varela E, Chang K, Stamos M, Wilson SE. Laparoscopic and thoracoscopic Ivor Lewis esophagectomy after Roux-en-Y gastric bypass. Ann Thorac Surg. 2006;82(5):1910–3. https://doi.org/10.1016/j.athoracsur.2006.02.065.
Corsini DA, Simoneti CA, Moreira G, Lima SE Jr, Garrido AB. Cancer in the excluded stomach 4 years after gastric bypass. Obes Surg. 2006;16(7):932–4. https://doi.org/10.1381/096089206777822313.
Harper JL, Beech D, Tichansky DS, Madan AK. Cancer in the bypassed stomach presenting early after gastric bypass. Obes Surg. 2007;17(9):1268–71. https://doi.org/10.1007/s11695-007-9216-x.
Watkins BJ, Blackmun S, Kuehner ME. Gastric adenocarcinoma after Roux-en-Y gastric bypass: access and evaluation of excluded stomach. Surg Obes Relat Dis. 2007;3(6):644–7. https://doi.org/10.1016/j.soard.2007.06.008.
Melstrom LG, Bentrem DJ, Salvino MJ, Blum MG, Talamonti MS, Printen KJ. Adenocarcinoma of the gastroesophageal junction after bariatric surgery. Am J Surg. 2008;196(1):135–8. https://doi.org/10.1016/j.amjsurg.2007.07.026.
Sun C, Jackson CS, Reeves M, Rendon S. Metastatic adenocarcinoma of the gastric pouch 5 years after Roux-en-Y gastric bypass. Obes Surg. 2008;18(3):345–8. https://doi.org/10.1007/s11695-007-9394-6.
Kuruba R, Jawad M, Karl RC, Murr MM. Technique of resection of esophageal adenocarcinoma after Roux-en-Y gastric bypass and literature review of esophagogastric tumors after bariatric procedures. Surg Obes Relat Dis. 2009;5(5):576–81. https://doi.org/10.1016/j.soard.2009.02.009.
Ribeiro MC, Lopes LR, de Souza Coelho Neto J, Tercioti V Jr, Andreollo NA. Gastric adenocarcinoma after gastric bypass for morbid obesity: a case report and review of the literature. Case Rep Med. 2013;2013:609727. https://doi.org/10.1155/2013/609727.
Menéndez P, Villarejo P, Padilla D. Krukenberg tumor after gastric bypass for morbid obesity. Bariatric surgery and gastric cancer. Rev Esp Enferm Dig. 2013;105(5):296–8. https://doi.org/10.4321/s1130-01082013000500009.
Kulaylat AN, Sahajwani S, Staveley-O’Carroll KF, Kaifi JT. Reconstructive options for gastroesophageal junction adenocarcinoma after Roux-en-Y gastric bypass. J Thorac Cardiovasc Surg. 2013;146(5):1296–8. https://doi.org/10.1016/j.jtcvs.2013.07.007.
Rossidis G, Browning R, Hochwald SN, Abbas H, Kim T, Ben-David K. Minimally invasive esophagectomy is safe in patients with previous gastric bypass. Surg Obes Relat Dis. 2014;10(1):95–100. https://doi.org/10.1016/j.soard.2013.03.015.
Nau P, Rattner DW, Meireles O. Linitis plastica presenting two years after elective Roux-en-Y gastric bypass for treatment of morbid obesity: a case report and review of the literature. Surg Obes Relat Dis. 2014;10(2):e15-7. https://doi.org/10.1016/j.soard.2013.06.015.
Magge D, Holtzman MP. Gastric Adenocarcinoma in patients with Roux-en-Y Gastric bypass: a case series. Surg Obes Relat Dis. 2015;11(5):e35-8. https://doi.org/10.1016/j.soard.2015.05.005.
Tinoco A, Gottardi LF, Boechat ED. gastric cancer in the excluded stomach 10 years after gastric bypass. Case Rep Surg. 2015;2015:468293. https://doi.org/10.1155/2015/468293.
Maret-Ouda J, Tao W, Mattsson F, Brusselaers N, El-Serag HB, Lagergren J. Esophageal adenocarcinoma after obesity surgery in a population-based cohort study. Surg Obes Relat Dis. 2017;13(1):28–34. https://doi.org/10.1016/j.soard.2015.09.016.
McFarland S, Manivel CJ, Ramaswamy A, Mesa H. Gastric-type extremely well-differentiated adenocarcinoma arising in the blind pouch of a bypassed stomach, presenting as colonic pseudo-obstruction. Ann Gastroenterol. 2015;28(4):499–501.
Fleetwood VA, Petersen L, Millikan KW. Gastric adenocarcinoma presenting after revisional Roux-en-Y gastric bypass. Am Surg. 2016;82(8):e186–7.
Midani D, Ehrlich AC, Kothari TH, Heller SJ. Gastric adenocarcinoma in an excluded stomach diagnosed by double balloon enteroscopy. Austin J Med Oncol. 2015;2:2–4.
Keren D, Madi H, Matter I, Assalia A, Rainis T. Feasibility and importance of enteroscopy after gastric bypass. Obes Surg. 2017;27(5):1309–15. https://doi.org/10.1007/s11695-016-2472-x.
van de Vrande S, Himpens J, Leman G. Adenocarcinoma of the gastric pouch after Roux-en-Y gastric bypass: a new technique for en bloc resection and reconstruction. Surg Obes Relat Dis. 2017;13(10):1793–5. https://doi.org/10.1016/j.soard.2017.07.006.
Runkel M, Runkel N. Esophago-gastric cancer after one anastomosis gastric bypass (OAGB). Chirurgia (Bucur). 2019;114(6):686–92. https://doi.org/10.21614/chirurgia.114.6.686.
Ruyssers M, Jawad R, Gys B, Gys T, Lafullarde T. Ivor Lewis oesophagectomy for a distal adenocarcinoma of the oesophagus 10 years after Roux-en-Y Gastric bypass (RYGB). Obes Surg. 2019;29(8):2713–4. https://doi.org/10.1007/s11695-019-03938-w.
Aggarwal S, Bhambri A, Singla V, Dash NR, Sharma A. Adenocarcinoma of oesophagus involving gastro-oesophageal junction following mini-gastric bypass/one anastomosis gastric bypass. J Minim Access Surg. 2019;16(2):175–8. https://doi.org/10.4103/jmas.JMAS_320_18.
Pastorello RG, de Macedo MP, da Costa Junior WL, Begnami MDFS. Gastric pouch mixed adenoneuroendocrine carcinoma with a mixed adenocarcinoma component after Roux-en-Y Gastric bypass. J Investig Med High Impact Case Rep. 2017;5(4):2324709617740908. https://doi.org/10.1177/2324709617740908.
Ali S, Chaar A, Frandah W, Altoos R, Sattar Z, Hasan M. Exploring the excluded stomach: a case series of novel endoscopic techniques to diagnose gastric cancer in the excluded stomach after Roux-en-Y gastric bypass surgery. Cureus. 2018;10(6):e2825. https://doi.org/10.7759/cureus.2825.
D’Antonio A, Borgheresi P, Addesso M. An unexpected adverse event of gastric bypass: giant hyperplastic polyp showing an intramucosal adenocarcinoma. Gastrointest Endosc. 2017;86(4):734–6. https://doi.org/10.1016/j.gie.2017.03.1537.
Haenen FW, Gys B, Moreels T, Michielsen M, Gys T, Lafullarde T. Linitis plastica of the bypassed stomach 7 years after Roux-en-Y gastric bypass: a case report. Acta Chir Belg. 2017;117(6):391–3. https://doi.org/10.1080/00015458.2016.1192839.
Ahmad W, Rubin J, Kwong W. Percutaneous endoscopy to diagnose malignancy in gastric outlet obstruction of excluded stomach after gastric bypass. Ann Gastroenterol. 2017;30(3):367–9. https://doi.org/10.20524/aog.2017.0132.
Chen W, Zhang G, Dong Z, Liu L, Wang Y, Chen X, Zhang J, Wang C. Cardia gastric cancer in the gastric pouch 5 years after gastric bypass: a case report. Obes Surg. 2020;30(5):2021–5. https://doi.org/10.1007/s11695-019-04336-y.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Ethics Approval
For this type of study, formal consent is not required.
Consent to Participate
Informed consent does not apply.
Conflict of Interest
The authors declare no competing interests.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Key points
• Mini gastric bypass does not seem to put the gastric pouch at a higher risk of gastroesophageal cancer development.
• A big proportion of gastroesophageal cancers after bypass surgeries occurs in the excluded stomach.
• Duodenogastric reflux is a physiologic process that might become harmful after gastric bypass surgeries.
• Attention is needed regarding the risk of cancer in the excluded stomach after gastric bypass surgeries.
Appendix
Appendix
Rights and permissions
About this article
Cite this article
Chemaly, R., Diab, S., Khazen, G. et al. Gastroesophageal Cancer After Gastric Bypass Surgeries: a Systematic Review and Meta-analysis. OBES SURG 32, 1300–1311 (2022). https://doi.org/10.1007/s11695-022-05921-4
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11695-022-05921-4